[D4] Navigating NASH: A Discussion on Clinical Background, Patient Advocacy and Managed Care Considerations

Pricing: Free for Members and Non-Members

This session was supported by Novo Nordisk, and the content was developed by AMCP and the faculty. This session is not accredited for continuing pharmacy education credit.

Course Description

Non-Alcoholic Steatohepatitis (NASH) is an underdiagnosed and underreported hidden and global epidemic affecting more than 115 million people worldwide. An estimated 357 million people will be affected by 2030.

Although no drug is currently FDA-approved for NASH, it is imperative that the medical community, including healthcare professionals, managed care professionals and patients work together to strategize solutions for each phase of the patient’s journey.

This session is designed to increase awareness of NASH among the managed care pharmacy audience. A trio of dynamic speakers, including an expert in the field, a representative from a patient advocacy group, and a managed care pharmacist will discuss the disease, the clinical and economic burden of the disease, access to care, and appropriate treatment.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Indicate the pathophysiology, epidemiology, and clinical and economic burdens of NASH to establish urgency in treatment.
  2. Recognize the NASH patient journey including the impact of diagnosis, challenges of access to care, and the importance of the patient involvement continuum.
  3. Discuss managed care benefit design challenges and strategies to optimize access to appropriate treatment.
Course summary
Available credit: 
  • 1.25 Certificate of Completion
Course opens: 
Course expires: 


Michael R. Charlton, MD
Professor of Medicine
Chief of Hepatology
Director, Center for Liver Diseases
Medical Director, Transplantation Institute
University of Chicago Medicine

Brian K. MacDonald, PharmD
Senior Director, Specialty Clinical Strategy and Innovation
Magellan Rx Management

Jeff J. McIntyre, MA
Vice President, Liver Health Programs
Global Liver Institute


Amy Lugo, PharmD, BCPS, BC-ADM
LoneStar Health Solutions


This session is not accredited for continuing pharmacy education credit.

Available Credit

  • 1.25 Certificate of Completion


Please login or register to take this course.

Required Hardware/software

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities